S&P 500   3,379.05 (+0.48%)
DOW   27,827.50 (+0.16%)
QQQ   281.80 (+1.43%)
AAPL   116.51 (+0.60%)
MSFT   212.09 (+0.84%)
FB   267.41 (+2.10%)
GOOGL   1,487.03 (+1.46%)
AMZN   3,206.28 (+1.83%)
TSLA   447.23 (+4.25%)
NVDA   544.54 (+0.61%)
BABA   289.95 (-1.37%)
CGC   14.27 (-0.35%)
MU   47.66 (+1.49%)
GE   6.17 (-0.96%)
AMD   84.16 (+2.65%)
T   28.61 (+0.35%)
F   6.74 (+1.20%)
ACB   4.67 (+0.43%)
GILD   63.00 (-0.30%)
NFLX   515.37 (+3.07%)
DIS   123.94 (-0.11%)
BA   167.66 (+1.45%)
BAC   24.06 (-0.12%)
S&P 500   3,379.05 (+0.48%)
DOW   27,827.50 (+0.16%)
QQQ   281.80 (+1.43%)
AAPL   116.51 (+0.60%)
MSFT   212.09 (+0.84%)
FB   267.41 (+2.10%)
GOOGL   1,487.03 (+1.46%)
AMZN   3,206.28 (+1.83%)
TSLA   447.23 (+4.25%)
NVDA   544.54 (+0.61%)
BABA   289.95 (-1.37%)
CGC   14.27 (-0.35%)
MU   47.66 (+1.49%)
GE   6.17 (-0.96%)
AMD   84.16 (+2.65%)
T   28.61 (+0.35%)
F   6.74 (+1.20%)
ACB   4.67 (+0.43%)
GILD   63.00 (-0.30%)
NFLX   515.37 (+3.07%)
DIS   123.94 (-0.11%)
BA   167.66 (+1.45%)
BAC   24.06 (-0.12%)
S&P 500   3,379.05 (+0.48%)
DOW   27,827.50 (+0.16%)
QQQ   281.80 (+1.43%)
AAPL   116.51 (+0.60%)
MSFT   212.09 (+0.84%)
FB   267.41 (+2.10%)
GOOGL   1,487.03 (+1.46%)
AMZN   3,206.28 (+1.83%)
TSLA   447.23 (+4.25%)
NVDA   544.54 (+0.61%)
BABA   289.95 (-1.37%)
CGC   14.27 (-0.35%)
MU   47.66 (+1.49%)
GE   6.17 (-0.96%)
AMD   84.16 (+2.65%)
T   28.61 (+0.35%)
F   6.74 (+1.20%)
ACB   4.67 (+0.43%)
GILD   63.00 (-0.30%)
NFLX   515.37 (+3.07%)
DIS   123.94 (-0.11%)
BA   167.66 (+1.45%)
BAC   24.06 (-0.12%)
S&P 500   3,379.05 (+0.48%)
DOW   27,827.50 (+0.16%)
QQQ   281.80 (+1.43%)
AAPL   116.51 (+0.60%)
MSFT   212.09 (+0.84%)
FB   267.41 (+2.10%)
GOOGL   1,487.03 (+1.46%)
AMZN   3,206.28 (+1.83%)
TSLA   447.23 (+4.25%)
NVDA   544.54 (+0.61%)
BABA   289.95 (-1.37%)
CGC   14.27 (-0.35%)
MU   47.66 (+1.49%)
GE   6.17 (-0.96%)
AMD   84.16 (+2.65%)
T   28.61 (+0.35%)
F   6.74 (+1.20%)
ACB   4.67 (+0.43%)
GILD   63.00 (-0.30%)
NFLX   515.37 (+3.07%)
DIS   123.94 (-0.11%)
BA   167.66 (+1.45%)
BAC   24.06 (-0.12%)
Log in
NYSE:APHA

Aphria Stock Forecast, Price & News

$4.43
0.00 (0.00 %)
(As of 10/1/2020 01:10 PM ET)
Add
Compare
Today's Range
$4.37
Now: $4.43
$4.44
50-Day Range
$4.22
MA: $4.55
$4.87
52-Week Range
$1.95
Now: $4.43
$6.15
Volume48,191 shs
Average Volume6.06 million shs
Market Capitalization$1.28 billion
P/E Ratio49.22
Dividend YieldN/A
Beta2.19
Aphria Inc. produces and sells medical cannabis in Canada and internationally. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It serves patients and health professionals. The company also sells its products online. Aphria Inc. is headquartered in Leamington, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 4.5Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.59 out of 5 stars


Industry, Sector and Symbol

Industry Medicinals & botanicals
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
PhoneN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$179.29 million
Book Value$5.23 per share

Profitability

Net Income$-12,480,000.00

Miscellaneous

Employees300
Market Cap$1.28 billion
Next Earnings Date10/20/2020 (Estimated)
OptionableNot Optionable
$4.43
0.00 (0.00 %)
(As of 10/1/2020 01:10 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive APHA News and Ratings via Email

Sign-up to receive the latest news and ratings for APHA and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Aphria (NYSE:APHA) Frequently Asked Questions

How has Aphria's stock price been impacted by Coronavirus?

Aphria's stock was trading at $2.70 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, APHA shares have increased by 62.2% and is now trading at $4.38.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Aphria?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aphria in the last year. There are currently 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Aphria
.

When is Aphria's next earnings date?

Aphria is scheduled to release its next quarterly earnings announcement on Tuesday, October 20th 2020.
View our earnings forecast for Aphria
.

How were Aphria's earnings last quarter?

Aphria Inc (NYSE:APHA) posted its quarterly earnings data on Wednesday, July, 29th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.03) by $0.07. The business earned $109.80 million during the quarter, compared to analysts' expectations of $105.64 million. Aphria had a negative return on equity of 0.30% and a net margin of 5.75%.
View Aphria's earnings history
.

What price target have analysts set for APHA?

8 brokerages have issued 12 month price objectives for Aphria's stock. Their forecasts range from $7.00 to $11.00. On average, they expect Aphria's stock price to reach $8.83 in the next year. This suggests a possible upside of 101.6% from the stock's current price.
View analysts' price targets for Aphria
.

Are investors shorting Aphria?

Aphria saw a decline in short interest during the month of September. As of September 15th, there was short interest totaling 35,140,000 shares, a decline of 10.3% from the August 31st total of 39,190,000 shares. Based on an average daily trading volume, of 5,290,000 shares, the days-to-cover ratio is currently 6.6 days. Currently, 12.2% of the company's shares are sold short.
View Aphria's Short Interest
.

Who are some of Aphria's key competitors?

What other stocks do shareholders of Aphria own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aphria investors own include Aurora Cannabis (ACB), Canopy Growth (CGC), Cronos Group (CRON), OrganiGram (OGI), Tilray (TLRY), NVIDIA (NVDA), Alibaba Group (BABA), KushCo (KSHB), Advanced Micro Devices (AMD) and HEXO (HEXO).

Who are Aphria's key executives?

Aphria's management team includes the following people:
  • Mr. Carl A. Merton, Chief Financial Officer
  • Ms. Megan McCrae, Director of Marketing
  • Mr. Irwin D. Simon, Interim CEO & Chairman
  • Mr. Jakob Ripshtein, Pres
  • Mr. Gary Leong, Chief Science Officer (Age 54)

What is Aphria's stock symbol?

Aphria trades on the New York Stock Exchange (NYSE) under the ticker symbol "APHA."

How do I buy shares of Aphria?

Shares of APHA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Aphria's stock price today?

One share of APHA stock can currently be purchased for approximately $4.38.

How big of a company is Aphria?

Aphria has a market capitalization of $1.26 billion and generates $179.29 million in revenue each year. The company earns $-12,480,000.00 in net income (profit) each year or ($0.11) on an earnings per share basis. Aphria employs 300 workers across the globe.

What is Aphria's official website?

The official website for Aphria is aphriainc.com.

How can I contact Aphria?

Aphria's mailing address is 245 TALBOT STREET W., LEAMINGTON A6, N8H 1N8.

This page was last updated on 10/1/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.